Acronym
Platform LNP vaccines
Code
42U09124
Duration
07 February 2024 → 31 December 2026
Funding
Funding by bilateral agreement (private and foundations)
Promotor
Research disciplines
-
Medical and health sciences
- Vaccinology
- Pharmaceutical analysis and quality assurance not elsewhere classified
- Pharmaceutical technology
- Physical pharmacy
-
Engineering and technology
- Manufacturing processes, methods and technologies
Keywords
mRNA
vaccine
lipid nanoparticle
continuous freezedrying
Project description
Within this project an innovative spinfreeze technology will be used to enhance the thermostability of mRNA vaccines. An analytical toolbox will be developed to analyse and understand the impact of the freeze drying process on the mRNA vaccines.